pharma · T2DM (Type 2 Diabetes Mellitus) · Type 2 Diabetes Mellitus · ORMP
Oramed Pharmaceuticals
ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 20 Mamilla Avenue, 3rd Floor, Jerusalem, 9414904, IL
- Founded
- 2006
- Employees
- 16
- Programs
- 14
- Drugs
- 8
- Patents
- 10
Oramed Pharmaceuticals clinical trials
Registry index of 16 ClinicalTrials.gov studies linked to Oramed Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Oramed Pharmaceuticals trial registry — 16 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Oramed Pharmaceuticals.
-
Oral Insulin — Phase 2
Clinical update -
ORMD-0801 (qd) — Phase 3
Clinical update -
ORMD-0801 Treatment A — Phase 2
Clinical update -
ORMD-0801 QD — Phase 2
Clinical update -
ORMD-0801 (Insulin) capsule 8 mg BD — Phase 2
Clinical update -
ORMD-0801 Dose # 1 — Phase 2
Clinical update -
ORMD-0801 Capsules — Phase 2
Clinical update -
ORMD-0801 capsules- 2x8mg — Phase 2
Clinical update